Elucidating the synthetic lethal effect of CDK inhibition in triple negative breast cancer

被引：0
|
作者：
Rohrberg, J.
Corella, A.
Starnes, L.
Goga, A.
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50327-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
367
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [11] Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple- Negative Breast Cancer
    Jabbour-Leung, Natalie A.
    Chen, Xian
    Bui, Tuyen
    Jiang, Yufeng
    Yang, Dong
    Vijayaraghavan, Smruthi
    McArthur, Mark J.
    Hunt, Kelly K.
    Keyomarsi, Khandan
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (04) : 593 - 607
  • [12] Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
    Prson Gautam
    Leena Karhinen
    Agnieszka Szwajda
    Sawan Kumar Jha
    Bhagwan Yadav
    Tero Aittokallio
    Krister Wennerberg
    Molecular Cancer, 15
  • [13] Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
    Shu, Shaokun
    Wu, Hua-Jun
    Ge, Jennifer Y.
    Zeid, Rhamy
    Harris, Isaac S.
    Jovanovic, Bojana
    Murphy, Katherine
    Wang, Binbin
    Qiu, Xintao
    Endress, Jennifer E.
    Reyes, Jaime
    Lim, Klothilda
    Font-Tello, Alba
    Syamala, Sudeepa
    Xiao, Tengfei
    Chilamakuri, Chandra Sekhar Reddy
    Papachristou, Evangelia K.
    D'Santos, Clive
    Anand, Jayati
    Hinohara, Kunihiko
    Li, Wei
    McDonald, Thomas O.
    Luoma, Adrienne
    Modiste, Rebecca J.
    Quang-De Nguyen
    Michel, Brittany
    Cejas, Paloma
    Kadoch, Cigall
    Jaffe, Jacob D.
    Wucherpfennig, Kai W.
    Qi, Jun
    Liu, X. Shirley
    Long, Henry
    Brown, Myles
    Carroll, Jason S.
    Brugge, Joan S.
    Bradner, James
    Michor, Franziska
    Polyak, Kornelia
    MOLECULAR CELL, 2020, 78 (06) : 1096 - +
  • [14] Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
    Gautam, Prson
    Karhinen, Leena
    Szwajda, Agnieszka
    Jha, Sawan Kumar
    Yadav, Bhagwan
    Aittokallio, Tero
    Wennerberg, Krister
    MOLECULAR CANCER, 2016, 15
  • [15] Investigating CDK4/6 inhibition in triple-negative breast cancer.
    Guo, Qiuchen
    Goreczny, Gregory J.
    Maynard, Adam
    Spasic, Milos
    McAllister, Sandra S.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 40 - 40
  • [16] Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
    Bajrami, Ilirjana
    Kigozi, Asha
    Van Weverwijk, Antoinette
    Brough, Rachel
    Frankum, Jessica
    Lord, Christopher J.
    Ashworth, Alan
    EMBO MOLECULAR MEDICINE, 2012, 4 (10) : 1087 - 1096
  • [17] Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer
    Rachel Brough
    Aditi Gulati
    Syed Haider
    Rahul Kumar
    James Campbell
    Erik Knudsen
    Stephen J. Pettitt
    Colm J. Ryan
    Christopher J. Lord
    Oncogene, 2018, 37 : 5701 - 5718
  • [18] Identification of Novel Synthetic-Lethal Targets for MYC-Driven Triple Negative Breast Cancer
    Goga, A.
    Samson, S.
    Horiuchi, D.
    CANCER RESEARCH, 2012, 72
  • [19] Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer
    Brough, Rachel
    Gulati, Aditi
    Haider, Syed
    Kumar, Rahul
    Campbell, James
    Knudsen, Erik
    Pettitt, Stephen J.
    Ryan, Coim J.
    Lord, Christopher J.
    ONCOGENE, 2018, 37 (43) : 5701 - 5718
  • [20] Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer
    Brough, R.
    Gulati, A.
    Haider, S.
    Kumar, R.
    Campbell, J.
    Knudsen, E.
    Pettitt, S.
    Ryan, C.
    Lord, C.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E141 - E142
12345